4 hours NRx Pharmaceuticals (NRXP) Upgraded to Buy: Here’s WhyZacks
NRx Pharmaceuticals (NRXP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
Current · Earnings · Pharmaceuticals
X